DiscoverLeading Corporate Transformation: The WHU Podcast, powered by PwCHelene von Roeder, CFO Merck – Combining Pharma, Life Science and Electronics in a Stock-Listed, Family-Owned Firm
Helene von Roeder, CFO Merck – Combining Pharma, Life Science and Electronics in a Stock-Listed, Family-Owned Firm

Helene von Roeder, CFO Merck – Combining Pharma, Life Science and Electronics in a Stock-Listed, Family-Owned Firm

Update: 2025-09-04
Share

Description

How do you steer a 350-year-old global science and technology company through complex transformation while balancing short-term market expectations and long-term family ownership?


In this episode, we speak with Helene von Roeder, CFO of Merck, a diversified company operating in healthcare, life sciences, and electronics. We explore how Merck navigates M&A strategy across highly specialized sectors, why capital allocation can be a competition between business units, and how conglomerate structure can be a strength - if properly managed.


Helene shares her views on pharma portfolio, the strategic rationale behind the $3B SpringWorks acquisition, and how internal R&D capabilities remain crucial even in a buy-to-innovate world. We also discuss the implications of tariffs, geopolitical uncertainty, and the evolving US-China dynamic for Merck’s global supply chain and investment logic.


Finally, Helene reflects on her own career path: from physics and investment banking to the executive floor and why failure, resilience, and a healthy dose of humility matter just as much as financial discipline.


Guest: Helene von Roeder, CFO of Merck KGaA


Hosts: Prof. Dr. Martin Glaum & Gori von Hirschhausen


Editorial Team: Simon Görlach, Annika Lux-Röhrig

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Helene von Roeder, CFO Merck – Combining Pharma, Life Science and Electronics in a Stock-Listed, Family-Owned Firm

Helene von Roeder, CFO Merck – Combining Pharma, Life Science and Electronics in a Stock-Listed, Family-Owned Firm

Prof. Dr. Serden Ozcan, Prof. Dr. Martin Glaum, Gori von Hirschhausen